Associate physician
Unidad médica de investigación de trombosis, hemostasia y aterogénesis, Instituto Mexicano del Seguro Social
Ciudad de México Maximino Avila Camacho, Distrito Federal, Mexico
Intagliata, N. M., Caldwell, S. H., & Tripodi, A. (2019). Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology, 156(6), 1582-1599.e1. https://doi.org/10.1053/j.gastro.2019.01.265
Leonardi, F., De Maria, N., & Villa, E. (2017). Anticoagulation in cirrhosis: a new paradigm? Clinical and molecular hepatology, 23(1), 13 21. https://doi.org/10.3350/cmh.2016.0110
Lisman, T., Kamphuisen, P. W., Northup, P. G., & Porte, R. J. (2013). Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveats. Journal of Hepatology, 59(2), 358-366. https://doi.org/10.1016/j.jhep.2013.03.027
MARIA LUISA ALCIVAR GARCIA
CEDULA PROFESIONAL. 12841112
MEDICO ESPECIALISTA EN HEMATOLOGIA
ALTA ESPECIALIDAD EN HEMOSTASIA Y TROMBOSIS
PB0430 - Treatment of APS patients with rivaroxaban or apixaban: A cohort single-center study.
Sunday, June 25, 2023
18:30 – 19:30 ET
Tuesday, June 27, 2023
18:30 – 19:30 ET
PB1055 - Chronic anticoagulation in patients with liver failure: A single-center cohort study.
Tuesday, June 27, 2023
18:30 – 19:30 ET